Skip to main content
. 2022 Mar 7;182(5):555–556. doi: 10.1001/jamainternmed.2022.0091

Table. Details of Prostate Cancer Screening Risks as Specified on Websites of US Cancer Centers.

Risks of screening mentioned No. (%)
All centers (n = 607) NCI-designated centers (n = 44) Non–NCI-designated centers (n = 563)
Overdiagnosis, overtreatment, or unnecessary treatment 56 (9.2) 15 (34.1) 41 (7.3)
False-positive results 47 (7.7) 4 (9.1) 43 (7.6)
False-negative results 13 (2.1) 2 (4.6) 11 (2.0)
States but does not specify risks 113 (18.6) 4 (9.1) 109 (19.4)
States that there are no risks 1 (0.2) 1 (2.3) 0
No discussion of risks 377 (62.1) 18 (40.9) 359 (63.8)

Abbreviation: NCI, National Cancer Institute.